AU2003295398A1 - Safer attenuated virus vaccines with missing or diminished latency of infection - Google Patents

Safer attenuated virus vaccines with missing or diminished latency of infection

Info

Publication number
AU2003295398A1
AU2003295398A1 AU2003295398A AU2003295398A AU2003295398A1 AU 2003295398 A1 AU2003295398 A1 AU 2003295398A1 AU 2003295398 A AU2003295398 A AU 2003295398A AU 2003295398 A AU2003295398 A AU 2003295398A AU 2003295398 A1 AU2003295398 A1 AU 2003295398A1
Authority
AU
Australia
Prior art keywords
diminished
safer
latency
missing
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003295398A
Other versions
AU2003295398A8 (en
Inventor
Jeffrey Irvine Cohen
Edward Michael Cox
Lesley M. Pesnicak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2003295398A1 publication Critical patent/AU2003295398A1/en
Publication of AU2003295398A8 publication Critical patent/AU2003295398A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003295398A 2002-11-05 2003-11-05 Safer attenuated virus vaccines with missing or diminished latency of infection Abandoned AU2003295398A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42360302P 2002-11-05 2002-11-05
US60/423,603 2002-11-05
PCT/US2003/035167 WO2004042031A2 (en) 2002-11-05 2003-11-05 Safer attenuated virus vaccines with missing or diminished latency of infection

Publications (2)

Publication Number Publication Date
AU2003295398A1 true AU2003295398A1 (en) 2004-06-07
AU2003295398A8 AU2003295398A8 (en) 2004-06-07

Family

ID=32312687

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003295398A Abandoned AU2003295398A1 (en) 2002-11-05 2003-11-05 Safer attenuated virus vaccines with missing or diminished latency of infection

Country Status (2)

Country Link
AU (1) AU2003295398A1 (en)
WO (1) WO2004042031A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006012092A2 (en) * 2004-06-29 2006-02-02 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Safer attenuated virus vaccines with missing or diminished latency of infection
WO2008079539A2 (en) 2006-11-09 2008-07-03 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Recombinant herpesvirus with diminished latency and methods of using same
CN101967466A (en) * 2009-07-28 2011-02-09 新泽西医学院 ORF7 auxotrophic varicella virus strain, vaccine containing same and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5341202B2 (en) * 1974-03-12 1978-11-01
US5837261A (en) * 1990-09-25 1998-11-17 Cantab Pharmaceuticals Research Limited Viral vaccines

Also Published As

Publication number Publication date
WO2004042031A3 (en) 2004-09-16
AU2003295398A8 (en) 2004-06-07
WO2004042031A2 (en) 2004-05-21

Similar Documents

Publication Publication Date Title
PL398575A1 (en) Vaccine composition against West Nile virus infection
EP1603590A4 (en) Influenza virus vaccine
IL189329A (en) Vaccination against dengue virus infection, kit and use of same
EP1594512A4 (en) Compounds for the treatment of viral infection
AU2001263443A1 (en) F-protein epitope-based vaccine for respiratory syncytial virus infection
EP1670507A4 (en) Vaccine for treatment and prevention of herpes simplex virus infection
AU2003216523A1 (en) Treatment of pre-core hepatitis b virus mutant infections
ZA200602871B (en) Compositions and methods for inhibiting White Spot Syndrome Virus (WSSV) infection
AU2003278776A1 (en) Codon-optimized polynucleotide-based vaccines against bacillus anthracis infection
EP1575505A3 (en) Codon-optimized polynucleotide-based vaccines against bacillus anthracis infection
AU2003294757A1 (en) Formulations useful against hepatitis c virus infections
AU2002307971A1 (en) Vaccine against the nile fever virus
AU2003279551A1 (en) Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
AU2002225509A1 (en) Production and of viruses, viral isolates and vaccines
ATE437656T1 (en) VACCINE AGAINST FORAL ACID VIRUS
AU2002322082A1 (en) Pharmaceutical composition for the treatment of viral infection
DK1372712T3 (en) Vaccine against equine herpes virus
AU2001278337A1 (en) Respiratory syncytial virus vaccine
AU2003295398A1 (en) Safer attenuated virus vaccines with missing or diminished latency of infection
AU2003900064A0 (en) A method of treatment or prophylaxis of viral infection.
AU2003301865A1 (en) Epitopes of hepatitis c virus
ZA200802176B (en) Vaccination against dengue virus infection
AU2002332613A1 (en) Compositions and therapeutic methods for viral infection
AU4957800A (en) Vaccine against isa virus
AU2003287216A1 (en) Gb virus c and methods of treating viral infections

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase